CN101850017B - Chinese medicament for treating asthma - Google Patents
Chinese medicament for treating asthma Download PDFInfo
- Publication number
- CN101850017B CN101850017B CN2009102354866A CN200910235486A CN101850017B CN 101850017 B CN101850017 B CN 101850017B CN 2009102354866 A CN2009102354866 A CN 2009102354866A CN 200910235486 A CN200910235486 A CN 200910235486A CN 101850017 B CN101850017 B CN 101850017B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chinese
- asthma
- angelica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明属于治疗呼吸病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating respiratory diseases.
背景技术Background technique
目前,旨在治疗哮喘的中药领域,存在着几个方面的不足:一是效果不够明显,二是见效比较迟缓。大批哮喘病患者因药物不能有效治疗和控制该病,以致哮喘反复发作、缠绵难愈,患者常常胸胀气粗、喉中有声、喘不得卧,非常痛苦。患者家属对此很不满意。At present, there are several deficiencies in the field of traditional Chinese medicine aimed at treating asthma: one is that the effect is not obvious enough, and the other is that the effect is relatively slow. A large number of asthma patients cannot effectively treat and control the disease due to drugs, resulting in recurrent attacks of asthma, lingering and difficult to heal. Patients often suffer from chest distension, thick breath, voice in the throat, and difficulty lying down while breathing, which is very painful. The patient's family members were very dissatisfied with this.
针对以上提出的问题,本发明提供一种治疗哮喘的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for treating asthma, which can solve the problem that the effect of traditional Chinese medicines in the past is not obvious enough, and the effect is relatively slow. The advantage of being faster.
发明内容Contents of the invention
本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:
1、一种治疗哮喘的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of asthma, adopts Chinese medicine raw material to prepare, and formula is (by weight):
麻黄4-30份 三七3-20份 熟地4-30份Ephedra 4-30 parts Panax notoginseng 3-20 parts Rehmannia glutinosa 4-30 parts
五味子4-30份 地龙4-30份 灵芝2-12份Schisandra 4-30 parts Dilong 4-30 parts Ganoderma lucidum 2-12 parts
当归4-30份 补骨脂4-30份Angelica 4-30 parts Psoralen 4-30 parts
这种治疗哮喘的中药是由下列方法制成的:This traditional Chinese medicine for asthma is made by the following method:
(1)按上述重量比,将麻黄、熟地、五味子、地龙、当归、补骨脂经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, extract ephedra, rehmannia glutinosa, schisandra chinensis, earthworm, angelica and psoralen through a conventional water extraction process to make extract powder;
(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.
本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝、熟地益气养血、滋肾填精,扶正培本,是为主药;辅以补骨脂补肾纳气;五味子补肾敛肺,以加强主药补肾益气之功,为辅药;佐以当归、三七活血化瘀;地龙下行利水,水行则气机和畅;麻黄宣肺行水,肺宣水行则喘定。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,补肾益肺,降气定喘之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum and Rehmannia glutinosa nourish Qi and blood, nourish the kidney and essence, and strengthen the body, which is the main medicine; supplemented with psoralen to nourish the kidney and absorb Qi; Medicine; adjuvant with Angelica, Panax notoginseng to promote blood circulation and remove blood stasis; earthworm descends to improve water, and the flow of water can make the movement of Qi smooth; All the medicines are compatible and complement each other. They play the role of strengthening the body, nourishing qi and blood, promoting blood circulation and removing blood stasis, nourishing the kidney and lung, lowering qi and relieving asthma. The effect is good and quick. advantage.
具体实施方式Detailed ways
通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:
1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):
麻黄60克 三七40克 熟地60克Ephedra 60g Sanqi 40g Shudi 60g
五味子60克 地龙60克 灵芝30克Schisandra 60g Earthworm 60g Ganoderma lucidum 30g
当归60克 补骨脂60克Angelica 60g Psoralen 60g
按规定重量,用常规水提取工艺将麻黄、熟地、五味子、地龙、当归、补骨脂提取,制成浸膏细粉108克,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊742粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, extract ephedra, rehmannia glutinosa, schisandra chinensis, earthworm, angelica, and psoralen with conventional water extraction process to make 108 grams of extract powder, grind Sanqi and Ganoderma lucidum into fine powder respectively, and mix with the above extract The fine powder is mixed, stirred evenly, made into fine particles, packed into No. 0 capsules, and made into 742 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.
2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):
麻黄160克 三七120克 熟地160克Ephedra 160g Sanqi 120g Shudi 160g
五味子160克 地龙160克 灵芝100克Schisandra 160g Earthworm 160g Ganoderma lucidum 100g
当归160克 补骨脂160克Angelica 160g Psoralen 160g
按上述同样的方法,制成中药胶囊1671粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1671 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):
麻黄300克 三七200克 熟地300克Ephedra 300g Sanqi 200g Rehmannia 300g
五味子300克 地龙300克 灵芝120克Schisandra 300g Earthworm 300g Ganoderma lucidum 120g
当归300克 补骨脂300克Angelica 300g Psoralen 300g
按上述同样的方法,制成中药胶囊3071粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, 3071 Chinese medicine capsules were made, and each capsule contained 0.28 grams of Chinese medicine fine powder and extract.
4、取以下配方(按重量比):4. Take the following formula (by weight):
麻黄6份 三七5份 熟地6份6 parts ephedra, 5 parts Panax notoginseng, 6 parts Shudi
五味子6份 地龙6份 灵芝3份Schisandra 6 parts Dilong 6 parts Ganoderma lucidum 3 parts
当归6份 补骨脂6份Angelica 6 parts Psoralen 6 parts
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
5、取以下配方(按重量比):5. Take the following formula (by weight):
麻黄20份 三七16份 熟地25份20 parts of Ephedra, 16 parts of Panax notoginseng, 25 parts of Rehmannia glutinosa
五味子20份 地龙20份 灵芝9份Schisandra 20 parts Dilong 20 parts Ganoderma lucidum 9 parts
当归25份 补骨脂20份Angelica 25 parts Psoralen 20 parts
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
临床资料:clinical information:
本发明以中医哮喘为例,经7例临床观察。选择中医诊断哮喘为标准:患者肢软乏力,身上没劲;常常胸闷、喘息、咳嗽、呼吸困难;哮喘呈季节性发作,或者冷哮,或者热哮;哮喘时胸胀气粗,声高息涌,喘不得卧。如上症状,即可确诊。在确诊观察的对象中,男性3例,女性4例,无其它严重疾病,年龄为57岁-79岁,平均年龄70.4岁。The present invention takes asthma of traditional Chinese medicine as an example, through clinical observation of 7 cases. Choose the criteria for the diagnosis of asthma in traditional Chinese medicine: the patient's limbs are weak and weak, and his body is dull; he often has chest tightness, wheezing, coughing, and dyspnea; asthma is a seasonal attack, or cold wheezing, or hot wheezing; Do not lie down. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 3 males and 4 females, without other serious diseases, aged 57-79 years, with an average age of 70.4 years.
疗效判定:Judgment of curative effect:
1、显效:体质增强,身上有劲;胸闷、咳嗽、呼吸困难明显缓解;哮喘发作次数减少,时间较短;提前2个月服用,冷哮或热哮发作几率降低。1. Significant effect: physical fitness is enhanced, body is strong; chest tightness, cough, and dyspnea are significantly relieved; the number of asthma attacks is reduced and the time is shorter; taking it 2 months in advance reduces the chance of cold or hot asthma attacks.
2、有效:体质增强,身上有劲;胸闷、喘息、咳嗽、呼吸困难有所缓解。2. Effective: Physical fitness is enhanced, body is strong; chest tightness, wheezing, coughing, and dyspnea are relieved.
3、无效:病症无变化。3. Ineffective: no change in symptoms.
临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日3次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用3个月后,症状明显改善。临床实验的7人中,显效3人,有效3人,无效1人,总有效率85.7%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 3 times a day, 4 capsules each time, each capsule contains 0.28 grams of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 3 months of taking, Symptoms improved significantly. Among the 7 people in the clinical trial, 3 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 85.7%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354866A CN101850017B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354866A CN101850017B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101850017A CN101850017A (en) | 2010-10-06 |
| CN101850017B true CN101850017B (en) | 2011-09-28 |
Family
ID=42801807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102354866A Expired - Fee Related CN101850017B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850017B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104688869A (en) * | 2015-03-19 | 2015-06-10 | 高彬 | TCM (Traditional Chinese Medicine) preparation for treating asthma and preparation method thereof |
-
2009
- 2009-10-16 CN CN2009102354866A patent/CN101850017B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101850017A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101884731B (en) | Traditional Chinese medicine for treating silicosis | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101884704B (en) | Traditional Chinese medicine for treating asthma | |
| CN101850083B (en) | Chinese medicament for treating asthma | |
| CN101897847B (en) | Traditional Chinese medicine for curing asthma | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101850018A (en) | Chinese medicine for treating cervical spondylosis | |
| CN101843775A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101850079B (en) | Chinese medicament for treating asthma | |
| CN101843796A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843736A (en) | Chinese medicament for treating asthma | |
| CN101843816B (en) | Chinese medicament for treating chronic nephritis | |
| CN101850014A (en) | Chinese medicine for treating asthma | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101843777B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843818B (en) | Chinese medicament for treating chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WEI DEZONG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20141218 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141218 Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui Patentee after: Wei Dezong Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Wei De Zong Document name: Notification of Termination of Patent Right |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20181016 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |